On Friday, Organigram Holdings Inc. announced it has sent its first shipment of bulk dried flower to Canndoc Ltd., one of Israel’s largest and most established medical cannabis producers, and a subsidiary of InterCure Ltd. Officials report the shipment is part of Organigram’s multi-year deal with Canndoc and is projected to be worth approximately $2.4M. Furthermore, Organigram disclosed it will provide a guaranteed 3,000 kg of high quality, indoor-grown dried flower product to Canndoc by December 31, 2021, for processing and distribution into the Israeli medical market. The partnership between the two producers reflects the value of an ongoing foreign investment that is working to advance growing technology.
– Mmp News Author, Medical Marijuana Program Connection, 08/14/2020 6:21:13 AM